192 related articles for article (PubMed ID: 23254151)
1. Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).
Oboho I; Abraham AG; Benning L; Anastos K; Sharma A; Young M; Burian P; Gandhi M; Cohen M; Szczech L
J Acquir Immune Defic Syndr; 2013 Apr; 62(4):388-95. PubMed ID: 23254151
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen.
Allavena C; Bach-Ngohou K; Billaud E; Sécher S; Dejoie T; Reliquet V; Fakhouri F; Raffi F
J Antimicrob Chemother; 2013 Dec; 68(12):2866-70. PubMed ID: 23818285
[TBL] [Abstract][Full Text] [Related]
3. Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.
Gatanaga H; Tachikawa N; Kikuchi Y; Teruya K; Genka I; Honda M; Tanuma J; Yazaki H; Ueda A; Kimura S; Oka S
AIDS Res Hum Retroviruses; 2006 Aug; 22(8):744-8. PubMed ID: 16910829
[TBL] [Abstract][Full Text] [Related]
4. Proximal tubular renal dysfunction or damage in HIV-infected patients.
Del Palacio M; Romero S; Casado JL
AIDS Rev; 2012; 14(3):179-87. PubMed ID: 22833061
[TBL] [Abstract][Full Text] [Related]
5. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
[TBL] [Abstract][Full Text] [Related]
6. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).
Peralta C; Scherzer R; Grunfeld C; Abraham A; Tien P; Devarajan P; Bennett M; Butch A; Anastos K; Cohen M; Nowicki M; Sharma A; Young M; Sarnak M; Parikh C; Shlipak M
HIV Med; 2014 May; 15(5):291-300. PubMed ID: 24313986
[TBL] [Abstract][Full Text] [Related]
7. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
Ding H; He Y; Li K; Yang J; Li X; Lu R; Gao W
Clin Immunol; 2007 May; 123(2):227-34. PubMed ID: 17360238
[TBL] [Abstract][Full Text] [Related]
8. Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients.
Campbell LJ; Dew T; Salota R; Cheserem E; Hamzah L; Ibrahim F; Sarafidis PA; Moniz CF; Hendry BM; Poulton M; Sherwood RA; Post FA
BMC Nephrol; 2012 Aug; 13():85. PubMed ID: 22883485
[TBL] [Abstract][Full Text] [Related]
9. Urinary α 1-microglobulin and β 2-microglobulin as markers of early kidney injury in HIV-positive male patients on tenofovir-based antiretroviral therapy.
Yu XL; Sun W; Liu L; Hong K; Song H
PLoS One; 2024; 19(6):e0303442. PubMed ID: 38885284
[TBL] [Abstract][Full Text] [Related]
10. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
Hall AM; Edwards SG; Lapsley M; Connolly JO; Chetty K; O'Farrell S; Unwin RJ; Williams IG
Am J Kidney Dis; 2009 Dec; 54(6):1034-42. PubMed ID: 19783343
[TBL] [Abstract][Full Text] [Related]
11. The level of the biomarkers at the time of nephrology consultation might predict the prognosis of acute kidney injury in hospitalized patients.
Renhua L; Miaolin C; Junlin W; Qingwei W; Xiaoping X; Huili D; Weiming Z; Zhaohui N; Jiaqi Q; Yan Y
Blood Purif; 2014; 38(2):89-95. PubMed ID: 25342236
[TBL] [Abstract][Full Text] [Related]
12. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
[TBL] [Abstract][Full Text] [Related]
13. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.
Labarga P; Barreiro P; Martin-Carbonero L; Rodriguez-Novoa S; Solera C; Medrano J; Rivas P; Albalater M; Blanco F; Moreno V; Vispo E; Soriano V
AIDS; 2009 Mar; 23(6):689-96. PubMed ID: 19262355
[TBL] [Abstract][Full Text] [Related]
14. Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation.
Ascher SB; Scherzer R; Estrella MM; Zhang WR; Muiru AN; Jotwani V; Grunfeld C; Parikh CR; Gustafson D; Young M; Sharma A; Cohen MH; Ng DK; Palella FJ; Witt MD; Ho K; Shlipak MG
Clin J Am Soc Nephrol; 2018 Sep; 13(9):1321-1329. PubMed ID: 30154221
[TBL] [Abstract][Full Text] [Related]
15. Urinary markers of kidney injury and kidney function decline in HIV-infected women.
Shlipak MG; Scherzer R; Abraham A; Tien PC; Grunfeld C; Peralta CA; Devarajan P; Bennett M; Butch AW; Anastos K; Cohen MH; Nowicki M; Sharma A; Young MA; Sarnak MJ; Parikh CR
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):565-73. PubMed ID: 23023103
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury.
Nickolas TL; O'Rourke MJ; Yang J; Sise ME; Canetta PA; Barasch N; Buchen C; Khan F; Mori K; Giglio J; Devarajan P; Barasch J
Ann Intern Med; 2008 Jun; 148(11):810-9. PubMed ID: 18519927
[TBL] [Abstract][Full Text] [Related]
17. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
18. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.
Kinai E; Hanabusa H
AIDS Res Hum Retroviruses; 2009 Apr; 25(4):387-94. PubMed ID: 19361280
[TBL] [Abstract][Full Text] [Related]
19. Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: a diagnostic accuracy study.
Nishijima T; Shimbo T; Komatsu H; Takano M; Tanuma J; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
J Infect Chemother; 2013 Oct; 19(5):850-7. PubMed ID: 23467792
[TBL] [Abstract][Full Text] [Related]
20. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
